Globally, almost 1 million people die from colorectal cancer annually, even though early detection offers a survival rate of over 90%. With nearly half of the eligible population still avoiding traditional screening due to its invasive nature, Proskope is revolutionizing diagnosis with a blood test that provides answers in hours, eliminating the barriers and delays that lead to late-stage discovery.